Astellas Pharma Inc.
Symbol: ALPMF
PNK
9.521
USDTrhová cena dnes
204.6593
Pomer P/E
-0.0691
Pomer PEG
17.07B
MRK Cap
- 0.00%
Výnos DIV
Astellas Pharma Inc. (ALPMF) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1587585 | 335687 | 396624 | 337283 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 102440 | 0 | 19784 | 21297 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 2039347 | 548036 | 446516 | 404001 | |||||||||||||||||||||
balance-sheet.row.inventory | 888590 | 248738 | 174386 | 153072 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 163520 | 62269 | 32428 | 28998 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 4679042 | 1194730 | 1049954 | 923354 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1170110 | 293742 | 286459 | 269044 | |||||||||||||||||||||
balance-sheet.row.goodwill | 1566168 | 418694 | 328411 | 303030 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 5029140 | 1453824 | 562496 | 623431 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 6595308 | 1872518 | 890907 | 926461 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 462124 | 144421 | 145028 | 141206 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 233139 | 45594 | 84169 | 72331 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 139541 | 18598 | 1 | -1 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 8600222 | 2374873 | 1406564 | 1409041 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 13279264 | 3569603 | 2456518 | 2332395 | |||||||||||||||||||||
balance-sheet.row.account-payables | 621308 | 185193 | 140236 | 130739 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1605013 | 472278 | 88546 | 157730 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 120932 | 38515 | 5137 | 32388 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1434596 | 447738 | 54217 | 676 | |||||||||||||||||||||
Deferred Revenue Non Current | 398707 | 0 | 121279 | 138943 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 220571 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 1902520 | 589739 | 585798 | 556672 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2369066 | 687890 | 222530 | 184676 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 200484 | 0 | 61461 | 55014 | |||||||||||||||||||||
balance-sheet.row.total-liab | 6962259 | 1973615 | 948564 | 872087 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 1133697 | 0 | 1167315 | 1212796 | |||||||||||||||||||||
balance-sheet.row.common-stock | 412004 | 103001 | 103001 | 103001 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 3417069 | 809400 | 908158 | 944261 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1880296 | 518678 | 340639 | 247512 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -526061 | 164909 | -1011159 | -1047262 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 6317005 | 1595988 | 1507954 | 1460308 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 13279264 | 3569603 | 2456518 | 2332395 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 6317005 | 1595988 | 1507954 | 1460308 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 13279264 | - | - | - | |||||||||||||||||||||
Total Investments | 490761 | 144421 | 110575 | 101879 | |||||||||||||||||||||
balance-sheet.row.total-debt | 3039609 | 920016 | 200007 | 212744 | |||||||||||||||||||||
balance-sheet.row.net-debt | 1554464 | 584329 | -176833 | -103242 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 40352 | 17045 | 132361 | 156886 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 157840 | 157840 | 105738 | 79684 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | -68238 | -51702 | -24209 | 5956 | |||||||||||||||||||||
cash-flows.row.account-receivables | -55948 | -55948 | -4849 | -8001 | |||||||||||||||||||||
cash-flows.row.inventory | -60036 | -60036 | -7086 | 24058 | |||||||||||||||||||||
cash-flows.row.account-payables | 29466 | 29466 | -12274 | -10101 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 34816 | 34816 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 138353 | 460340 | 113877 | 14918 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 175050 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -82497 | -82497 | -88541 | -76448 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | -784974 | -784974 | 0 | -670 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -5576 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 12624 | 5576 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | 19094 | 12819 | -8583 | 14705 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -848377 | -854652 | -84500 | -62413 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -805689 | -771233 | -50000 | -60000 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | -216772 | 0 | 18505 | -17815 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -10735 | -10735 | -60556 | -50717 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -116653 | -116653 | -100355 | -85236 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | 1680968 | -16539 | -3217 | -2530 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 614060 | 614060 | -195623 | -216298 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 18113 | 18113 | 13210 | 11125 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | -41153 | -41153 | 60854 | -10142 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1485145 | 335687 | 376840 | 315986 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1526298 | 376840 | 315986 | 326128 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 175050 | 181325 | 327767 | 257444 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -82497 | -82497 | -88541 | -76448 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 92553 | 98828 | 239226 | 180996 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1603671 | 1603672 | 1518619 | 1296163 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 325131 | 391305 | 288353 | 253009 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 1278540 | 1212367 | 1230266 | 1043154 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 294187 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 546961 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 1180111 | 1034297 | 1098709 | 912191 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1505242 | 1425602 | 1387062 | 1165200 | |||||||||||||||||||||
income-statement-row.row.interest-income | 11454 | 11455 | 8110 | 6149 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 12005 | 12005 | 8779 | 4949 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -83431 | -149936 | -99291 | -61259 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -83431 | -149936 | -99291 | -61259 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 12005 | 12005 | 8779 | 4949 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 157840 | 157840 | 105738 | 79684 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 263138 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 107704 | 178070 | 133029 | 155686 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 23534 | 28134 | 132361 | 156886 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7924 | 7924 | 33647 | 32800 | |||||||||||||||||||||
income-statement-row.row.net-income | 12905 | 17045 | 98714 | 124086 |
Často kladené otázky
Čo je Astellas Pharma Inc. (ALPMF) celkové aktíva?
Astellas Pharma Inc. (ALPMF) celkové aktíva sú 3569603000000.000.
Aký je ročný obrat podniku?
Ročné príjmy sú 836534000000.000.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.797.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 51.622.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.008.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.067.
Aká je Astellas Pharma Inc. (ALPMF) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 17045000000.000.
Aký je celkový dlh firmy?
Celkový dlh je 920016000000.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 1034297000000.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 335687000000.000.